Casma
is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders... Read moreCasma
is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders... Read more
News
May 17, 2022
StreetInsider
Press Release: Casma : Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference
Apr 07, 2022
StreetInsider
Press Release: Casma : Casma Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference
Nov 10, 2021
GlobeNewswire
Press Release: Casma : Casma Therapeutics to Present at 2021 Stifel Virtual Healthcare Conference
Oct 04, 2021
GlobeNewswire
Press Release: Casma : Casma Therapeutics Announces Publication in Science Advances Highlighting Novel Mechanism Related to TFEB Activation and Lysosomal Biology
Sep 15, 2021
MarketScreener
Casma: Casma Therapeutics to Present at the UBS Virtual Biotechnology Private Company Symposium
Sep 13, 2021
GlobalNewswire
Press Release: Casma : Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
May 14, 2021
GlobeNewswire
Press Release: Casma : Casma Therapeutics to Present at Oppenheimer Rare & Orphan Disease Summit
Dec 01, 2020
FinanzNachrichten
Casma: Casma Therapeutics, Inc.: Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
Nov 17, 2020
Boston Citybizlist
Casma: Casma Therapeutics Appoints Nagesh Mahanthappa, Ph.D., MBA, to Board
Nov 17, 2020
MarketScreener
Casma: Casma Therapeutics Appoints Nagesh Mahanthappa, Ph.D., MBA, to Board of Directors
Casma Competitors
1
2
3
4
5
6
7
8
9
10